Table 1 Basic characteristics of patients at baseline (n = 50)
From: Clinical effect of conbercept on improving diabetic macular ischemia by OCT angiography
Ischemic Group (n = 31) | Non-ischemic Group (n = 19) | Total (n = 50) | |
|---|---|---|---|
Gender, n | |||
Male | 17 (55%) | 7 (49%) | 24 (48%) |
Female | 14 (45%) | 12 (51%) | 26 (52%) |
Age, years | 55.8 ± 8.5 | 55.8 ± 8.4 | 55.8 ± 8.4 |
BCVA, logMAR units | 0.64 ± 0.34 | 0.56 ± 0.34 | 0.61 ± 0.34 |
Duration of Diabetes, years | 10.1 ± 4.5 | 8.2 ± 4.9 | 9.4 ± 4.7 |
Stage of DR, n | |||
Mild NPDR | 0 (0) | 0 (0) | 0 (0) |
Moderate NPDR | 4 (13%) | 3 (16%) | 7 (14%) |
Severe NPDR | 21 (68%) | 13 (68%) | 34 (68%) |
PDR | 6 (19%) | 3 (16%) | 9 (18%) |
GHb,% | 9.6 ± 2.1 | 9.7 ± 2.0 | 9.6 ± 2.0 |
Complication | |||
Hypertension | 7 | 2 | 9 |
Renal Failure | 2 | 2 | 4 |
Others | 0 | 1 | 1 |
CFT(1 mm), μm | 328 ± 109 | 430 ± 118 | 367 ± 122 |
FAZ area, mm2 | 0.510 ± 0.171 | 0.364 ± 0.127 | 0.455 ± 0.171 |
Vessel Density,% | |||
Superficial (ILM-IPL) | 41.1 ± 4.1 | 44.8 ± 3.2 | 42.5 ± 4.2 |
Deep (IPL-OPL) | 40.7 ± 4.4 | 44.8 ± 3.2 | 41.8 ± 4.3 |